Request Deal Involvement

Roche completed the acquisition of Inflazome for €380m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

FTI Consulting

pr advisors

FTI Consulting

ByrneWallace

legal advisors

ByrneWallace

Goodwin Procter

legal advisors

Goodwin Procter

Lazard

financial advisors

Lazard

A&L Goodbody

legal advisors

A&L Goodbody

or

Principals

ROCHE HOLDINGS AG

bidder

ROCHE HOLDINGS AG

INFLAZOME

target

INFLAZOME

LONGITUDE CAPITAL MANAGEMENT CO LLC

vendor

LONGITUDE CAPITAL MANAGEMENT CO LLC

NOVARTIS AG

vendor

NOVARTIS AG

FOUNTAIN HEALTHCARE PARTNERS

vendor

FOUNTAIN HEALTHCARE PARTNERS

FORBION CAPITAL PARTNERS

vendor

FORBION CAPITAL PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Roche completed the acquisition of Inflazome for €380m.